IDEXX LABORATORIES INC /DE Investing Cash Flow
IDEXX LABORATORIES INC /DE (IDXX) reported Investing Cash Flow of -$59.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$25.50M.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$33.54M.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$28.13M.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$44.87M.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) investing activities for fiscal 2025 was -$136.24M.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) investing activities for fiscal 2024 was -$207.06M.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) investing activities for fiscal 2023 was -$125.25M.
- IDEXX LABORATORIES INC /DE net cash provided by (used in) investing activities for fiscal 2022 was -$195.35M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$25.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$59.04M 10-Q · filed 2026-08-04 | -$87.17M derived: sum of 3 quarters · filed 2026-08-04 | -$132.04M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$33.54M 10-Q · filed 2026-05-05 | -$61.67M derived: sum of 2 quarters · filed 2026-05-05 | -$106.55M derived: sum of 3 quarters · filed 2026-05-05 | -$140.17M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$28.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$73.00M derived: sum of 2 quarters · filed 2026-02-20 | -$106.63M derived: sum of 3 quarters · filed 2026-08-04 | -$136.24M 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | -$44.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$78.50M derived: sum of 2 quarters · filed 2026-08-04 | -$108.11M 10-Q · filed 2025-11-03 | -$147.95M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | -$33.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$63.24M 10-Q · filed 2026-08-04 | -$103.08M derived: sum of 3 quarters · filed 2026-08-04 | -$130.45M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | -$29.61M 10-Q · filed 2026-05-05 | -$69.45M derived: sum of 2 quarters · filed 2026-05-05 | -$96.82M derived: sum of 3 quarters · filed 2026-05-05 | -$129.73M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$39.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$67.21M derived: sum of 2 quarters · filed 2026-02-20 | -$100.12M derived: sum of 3 quarters · filed 2026-02-20 | -$207.06M 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | -$27.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$60.27M derived: sum of 2 quarters · filed 2025-11-03 | -$167.22M 10-Q · filed 2025-11-03 | -$197.65M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-06-30 | -$32.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$139.85M 10-Q · filed 2025-08-04 | -$170.29M derived: sum of 3 quarters · filed 2026-02-20 | -$198.12M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-03-31 | -$106.94M 10-Q · filed 2025-05-01 | -$137.38M derived: sum of 2 quarters · filed 2026-02-20 | -$165.22M derived: sum of 3 quarters · filed 2026-02-20 | -$192.69M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | -$30.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$58.27M derived: sum of 2 quarters · filed 2026-02-20 | -$85.74M derived: sum of 3 quarters · filed 2026-02-20 | -$125.25M 10-K · filed 2026-02-20 | ||||
| 2023-09-30 | -$27.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$55.31M derived: sum of 2 quarters · filed 2024-10-31 | -$94.82M 10-Q · filed 2024-10-31 | -$144.05M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | -$27.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$66.98M 10-Q · filed 2024-08-06 | -$116.21M derived: sum of 3 quarters · filed 2025-02-21 | -$165.41M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | -$39.51M 10-Q · filed 2024-05-01 | -$88.74M derived: sum of 2 quarters · filed 2025-02-21 | -$137.94M derived: sum of 3 quarters · filed 2025-02-21 | -$193.02M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | -$49.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$98.43M derived: sum of 2 quarters · filed 2025-02-21 | -$153.51M derived: sum of 3 quarters · filed 2025-02-21 | -$195.35M 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | -$49.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$104.28M derived: sum of 2 quarters · filed 2023-11-01 | -$146.12M 10-Q · filed 2023-11-01 | -$190.16M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | -$55.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$96.92M 10-Q · filed 2023-08-01 | -$140.96M derived: sum of 3 quarters · filed 2024-02-22 | -$190.64M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | -$41.84M 10-Q · filed 2023-05-02 | -$85.88M derived: sum of 2 quarters · filed 2024-02-22 | -$135.56M derived: sum of 3 quarters · filed 2024-02-22 | -$310.22M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | -$44.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$93.72M derived: sum of 2 quarters · filed 2024-02-22 | -$268.38M derived: sum of 3 quarters · filed 2024-02-22 | -$292.97M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | -$49.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$224.34M derived: sum of 2 quarters · filed 2022-11-01 | -$248.93M 10-Q · filed 2022-11-01 | -$264.62M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-06-30 | -$174.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$199.25M 10-Q · filed 2022-08-02 | -$214.94M derived: sum of 3 quarters · filed 2023-02-16 | -$234.40M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-03-31 | -$24.59M 10-Q · filed 2022-05-04 | -$40.28M derived: sum of 2 quarters · filed 2023-02-16 | -$59.74M derived: sum of 3 quarters · filed 2023-02-16 | -$84.29M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2020-12-31 | -$15.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$35.15M derived: sum of 2 quarters · filed 2023-02-16 | -$59.71M derived: sum of 3 quarters · filed 2023-02-16 | -$109.38M 10-K · filed 2023-02-16 | ||||
| 2020-09-30 | -$19.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$44.02M derived: sum of 2 quarters · filed 2021-11-02 | -$93.69M 10-Q · filed 2021-11-02 | -$189.60M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | -$24.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$74.23M 10-Q · filed 2021-07-30 | -$170.14M derived: sum of 3 quarters · filed 2022-02-16 | -$207.46M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | -$49.67M 10-Q · filed 2021-05-04 | -$145.58M derived: sum of 2 quarters · filed 2022-02-16 | -$182.91M derived: sum of 3 quarters · filed 2022-02-16 | -$216.99M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | -$95.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$133.24M derived: sum of 2 quarters · filed 2022-02-16 | -$167.32M derived: sum of 3 quarters · filed 2022-02-16 | -$205.53M 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | -$37.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$71.41M derived: sum of 2 quarters · filed 2020-10-29 | -$109.62M 10-Q · filed 2020-10-29 | -$149.46M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | -$34.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$72.29M 10-Q · filed 2020-07-31 | -$112.14M derived: sum of 3 quarters · filed 2021-02-12 | -$166.35M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | -$38.21M 10-Q · filed 2020-04-30 | -$78.05M derived: sum of 2 quarters · filed 2021-02-12 | -$132.26M derived: sum of 3 quarters · filed 2021-02-12 | -$159.92M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | -$39.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$94.06M derived: sum of 2 quarters · filed 2021-02-12 | -$121.71M derived: sum of 3 quarters · filed 2021-02-12 | $138.60M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | -$54.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$81.87M derived: sum of 2 quarters · filed 2019-10-31 | $178.45M 10-Q · filed 2019-10-31 | $153.96M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-06-30 | -$27.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $232.66M 10-Q · filed 2019-08-01 | $208.17M derived: sum of 3 quarters · filed 2020-02-14 | $166.69M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-03-31 | $260.31M 10-Q · filed 2019-05-01 | $235.82M derived: sum of 2 quarters · filed 2020-02-14 | $194.34M derived: sum of 3 quarters · filed 2020-02-14 | $150.64M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2017-12-31 | -$24.49M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | -$65.97M derived: sum of 2 quarters · filed 2020-02-14 | -$109.68M derived: sum of 3 quarters · filed 2020-02-14 | -$138.69M 10-K · filed 2020-02-14 | ||||
| 2017-09-30 | -$41.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$85.19M derived: sum of 2 quarters · filed 2018-11-01 | -$114.20M 10-Q · filed 2018-11-01 | |||||
| 2017-06-30 | -$43.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$72.71M 10-Q · filed 2018-08-01 | ||||||
| 2017-03-31 | -$29.01M 10-Q · filed 2018-05-04 | |||||||
| 2015-06-30 | -$66.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$227.59M 10-Q · filed 2015-07-30 | -$263.20M derived: sum of 3 quarters · filed 2015-07-30 | -$286.65M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2015-03-31 | -$160.62M 10-Q · filed 2015-04-28 | -$196.24M derived: sum of 2 quarters · filed 2015-04-28 | -$219.69M derived: sum of 3 quarters · filed 2015-04-28 | -$228.40M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2014-12-31 | -$35.62M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$59.07M derived: sum of 2 quarters · filed 2015-02-17 | -$67.78M derived: sum of 3 quarters · filed 2015-07-30 | -$80.41M 10-K · filed 2015-02-17 | ||||
| 2014-09-30 | -$23.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | -$32.16M derived: sum of 2 quarters · filed 2015-07-30 | -$44.80M 10-Q · filed 2014-10-24 | -$61.77M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2014-06-30 | -$8.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$21.35M 10-Q · filed 2015-07-30 | -$38.32M derived: sum of 3 quarters · filed 2015-07-30 | -$64.06M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2014-03-31 | -$12.63M 10-Q · filed 2015-04-28 | -$29.61M derived: sum of 2 quarters · filed 2015-04-28 | -$55.35M derived: sum of 3 quarters · filed 2015-04-28 | -$81.40M derived: sum of 4 quarters · filed 2015-04-28 | ||||
| 2013-12-31 | -$16.98M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$42.72M derived: sum of 2 quarters · filed 2015-02-17 | -$68.77M derived: sum of 3 quarters · filed 2015-02-17 | -$86.06M 10-K · filed 2015-02-17 | ||||
| 2013-09-30 | -$25.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | -$51.79M derived: sum of 2 quarters · filed 2014-10-24 | -$69.08M 10-Q · filed 2014-10-24 | -$68.23M 10-Q · filed 2013-10-22 | -$86.13M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-06-30 | -$26.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | -$43.34M 10-Q · filed 2014-07-25 | -$40.86M 10-Q · filed 2013-07-23 | -$60.39M derived: sum of 3 quarters · filed 2015-02-17 | -$79.31M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-03-31 | -$17.29M 10-Q · filed 2014-04-25 | -$16.92M 10-Q · filed 2013-04-23 | -$34.34M derived: sum of 2 quarters · filed 2015-02-17 | -$53.27M derived: sum of 3 quarters · filed 2015-02-17 | -$68.08M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2012-12-31 | -$17.05M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$35.98M derived: sum of 2 quarters · filed 2015-02-17 | -$50.79M derived: sum of 3 quarters · filed 2015-02-17 | -$58.13M 10-K · filed 2015-02-17 | -$66.00M 10-K · filed 2013-02-19 | |||
| 2012-09-30 | -$18.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | -$33.74M derived: sum of 2 quarters · filed 2013-10-22 | -$41.09M 10-Q · filed 2013-10-22 | -$95.99M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2012-06-30 | -$14.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23 | -$22.16M 10-Q · filed 2013-07-23 | -$77.06M derived: sum of 3 quarters · filed 2014-02-18 | -$93.41M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2012-03-31 | -$7.34M 10-Q · filed 2013-04-23 | -$62.25M derived: sum of 2 quarters · filed 2014-02-18 | -$78.60M derived: sum of 3 quarters · filed 2014-02-18 | -$95.06M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2011-12-31 | -$54.91M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | -$71.25M derived: sum of 2 quarters · filed 2014-02-18 | -$87.72M derived: sum of 3 quarters · filed 2014-02-18 | -$94.21M 10-K · filed 2014-02-18 | -$97.00M 10-K · filed 2012-02-17 | |||
| 2011-09-30 | -$16.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-19 | -$32.81M derived: sum of 2 quarters · filed 2012-10-19 | -$39.30M 10-Q · filed 2012-10-19 | -$53.69M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2011-06-30 | -$16.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-20 | -$22.95M 10-Q · filed 2012-07-20 | -$37.34M derived: sum of 3 quarters · filed 2013-02-19 | -$48.63M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2011-03-31 | -$6.49M 10-Q · filed 2012-04-20 | -$20.88M derived: sum of 2 quarters · filed 2013-02-19 | -$32.17M derived: sum of 3 quarters · filed 2013-02-19 | -$41.09M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2010-12-31 | -$14.39M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | -$25.67M derived: sum of 2 quarters · filed 2013-02-19 | -$34.60M derived: sum of 3 quarters · filed 2013-02-19 | -$43.19M 10-K · filed 2013-02-19 | ||||
| 2010-09-30 | -$11.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-21 | -$20.21M derived: sum of 2 quarters · filed 2011-10-21 | -$28.80M 10-Q · filed 2011-10-21 | -$42.82M derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2010-06-30 | -$8.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-22 | -$17.52M 10-Q · filed 2011-07-22 | -$31.53M derived: sum of 3 quarters · filed 2012-02-17 | -$52.23M derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2010-03-31 | -$8.59M 10-Q · filed 2011-04-21 | -$22.60M derived: sum of 2 quarters · filed 2012-02-17 | -$43.30M derived: sum of 3 quarters · filed 2012-02-17 | |||||
| 2009-12-31 | -$14.01M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | -$34.71M derived: sum of 2 quarters · filed 2012-02-17 | -$53.62M 10-K · filed 2012-02-17 | |||||
| 2009-09-30 | -$20.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-22 | -$39.61M 10-Q · filed 2010-10-22 | ||||||
| 2009-06-30 | -$18.91M 10-Q · filed 2010-07-23 | |||||||
| 2008-12-31 | -$91.59M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |